The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Abstract
Interleukin-6, an inflammatory cytokine, is characterized by pleiotropy and redundancy of action. Apart from its hematologic, immune, and hepatic effects, it has many endocrine and metabolic actions. Specifically, it is a potent stimulator of the hypothalamic-pituitary-adrenal axis and is under the tonic negative control of glucocorticoids. It acutely stimulates the secretion of growth hormone, inhibits thyroid-stimulating hormone secretion, and decreases serum lipid concentrations. Furthermore, it is secreted during stress and is positively controlled by catecholamines. Administration of interleukin-6 results in fever, anorexia, and fatigue. Elevated levels of circulating interleukin-6 have been seen in the steroid withdrawal syndrome and in the severe inflammatory, infectious, and traumatic states potentially associated with the inappropriate secretion of vasopressin. Levels of circulating interleukin-6 are also elevated in several inflammatory diseases, such as rheumatoid arthritis. Interleukin-6 is negatively controlled by estrogens and androgens, and it plays a central role in the pathogenesis of the osteoporosis seen in conditions characterized by increased bone resorption, such as sex-steroid deficiency and hyperparathyroidism. Overproduction of interleukin-6 may contribute to illness during aging and chronic stress. Finally, administration of recombinant human interleukin-6 may serve as a stimulation test for the integrity of the hypothalamic-pituitary-adrenal axis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These autoimmune diseases are associated with dysregulated production of IL-6 in humans (41–43) and impaired activation of the HPA axis in both humans (44) and animal models (1).”
From Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) · cites this paper as [43]
In the citing paper
“In this study, we provide evidence of one core pathway behind the diverse health risks associated with caregiving and other chronic stressors: overproduction of IL-6, a key proinflammatory cytokine that appears to enhance morbidity and mortality among older adults (10).”
From Chronic stress and age-related increases in the proinflammatory cytokine IL-6. (2003) · cites this paper as [10]
In the citing paper
“overproduction of IL-6, a key proinflammatory cytokine that appears to enhance morbidity and mortality among older adults (10).”
From Chronic stress and age-related increases in the proinflammatory cytokine IL-6. (2003) · cites this paper as [10]
In the citing paper
“IL-6 is associated with a variety of age-related illnesses (10, 13-15, 38).”
From Chronic stress and age-related increases in the proinflammatory cytokine IL-6. (2003) · cites this paper as [10]
In the citing paper
“However, with increasing recognition that inflammation is a key pathogenic mechanism in many infectious, autoimmune, cardiovascular, and psychiatric diseases (11–13), the adequacy of this explanation has been called into question (14–15).”
From A Functional Genomic Fingerprint of Chronic Stress in Humans: Blunted Glucocorticoid and Increased NF-κB Signaling (2008) · cites this paper as [12]
In the citing paper
“This profile suggests a scenario in which long-term stress brings about a functional resistance to glucocortioid signal transduction in monocytes, which reduces inhibition of NF-κB and EGR1, and thereby fosters the kind of pro-inflammatory dynamics that ultimately promote chronic diseases, including diabetes, coronary disease, autoimmune disorders, chronic infections, and some cancers (11–13).”
From A Functional Genomic Fingerprint of Chronic Stress in Humans: Blunted Glucocorticoid and Increased NF-κB Signaling (2008) · cites this paper as [12]
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationImpaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Self-citationIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440
Self-citationInterleukin-6 family of cytokines and gp130.
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,362
Kishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,318
Noradrenergic and peptidergic innervation of lymphoid tissue
Felten, D. L., Felten, S. Y., Carlson, S. L., Olschowka, J. A., & Livnat, S. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.755 · Cited by 1,025 · cited 1×
“Because it innervates many immune organs, such as the spleen and the thymus, the autonomic nervous system interacts directly with the immune system (33, 34).”
BackgroundSchindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., & Mucke, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10061 · Cited by 1,006
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3950 · Cited by 974
Self-citationMatsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome
WARTOFSKY, L., & BURMAN, K. D. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-164 · Cited by 916
van Deventer, S. J. H., Buller, H. R., ten Cate, J. W., Aarden, L. A., Hack, C. E., & Sturk, A. (1990) · Blood · doi:10.1182/blood.v76.12.2520.bloodjournal76122520 · Cited by 850
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R. F., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 745
Demitrack, M. A., Dale, J. K., Straus, S. E., Laue, L., LISTWAK, S. J., Kruesi, M. J. P., Chrousos, G. P., & Gold, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1224 · Cited by 727
Self-citationRepression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 702
Girasole, G., Jilka, R. L., Passeri, G., Boswell, S. H., Boder, G. B., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 677
Self-citationRecombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos, G., Chrousos, G. P., & Weber, J. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263159 · Cited by 591
Self-citationIgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
Linker‐Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri-Chen, T., & Klinenberg, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.117 · Cited by 545
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Cytokine appearance in human endotoxemia and primate bacteremia.
HESSE, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Cerami, A., Shires, G. T., & Lowry, S. F. (1988) · PubMed · Cited by 532
Defective inflammatory response in interleukin 6-deficient mice.
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., & Poli, V (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1243 · Cited by 525
Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia
Crofford, L. J., Pillemer, S. R., Kalogeras, K. T., Cash, J. M., Michelson, D., Kling, M. A., Sternberg, E. M., Gold, P. W., Chrousos, G. P., & Wilder, R. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371105 · Cited by 508
Self-citationInterleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
The Association of Plasma IL-6 Levels With Functional Disability in Community-Dwelling Elderly
Cohen, H. J., Pieper, C. F., Harris, T., Rao, K. M. K., & Currie, M. S. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.4.m201 · Cited by 476
Neuroendocrine-Immune System Interactions and Autoimmunity
Wilder, R. L. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001515 · Cited by 457
Self-citationBellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H. E., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 429
Self-citationNaitoh, Y., Fukata, J., Tominaga, T., Nakai, Y., Tamai, S., Mori, K., & Imura, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81305-6 · Cited by 421
Elenkov, I. J., Papanicolaou, D. A., Wilder, R. L., & Chrousos, G. P. (1996) · PubMed · Cited by 419
Self-citationMurine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J.-M., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 417
The alphas, betas, and kinases of cytokine receptor complexes
Stahl, N., & Yancopoulos, G. D. (1993) · Cell · doi:10.1016/0092-8674(93)90506-l · Cited by 405
Interleukin-11: a new cytokine critical for osteoclast development.
Girasole, G., Passeri, G., Jilka, R. L., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117130 · Cited by 395
Self-citationLoppnow, H., & Libby, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114498 · Cited by 378
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
Roodman, G. D., Kurihara, N., Ohsaki, Y., Kukita, A., Hosking, D., Demulder, A., SMITH, J. F., & Singer, F. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115584 · Cited by 363
HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease
Merrill, J. E., & Chen, I. S. Y. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.10.2065887 · Cited by 355
(1993) · PubMed · Cited by 330
Dalrymple, S., Lucian, L., Slattery, R., McNeil, T., Aud, D., Fuchino, S., Lee, F., & Murray, R. (1995) · Infection and Immunity · doi:10.1128/iai.63.6.2262-2268.1995 · Cited by 330
Ray, A., Prefontaine, K. E., & Ray, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99966-7 · Cited by 298
Drenth, J. P. H., Uum, S. H. M. V., van Deuren, M., Pesman, G. J., van der Ven‐Jongekrijg, J., & van der Meer, J. W. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.5.1497 · Cited by 294
Mastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H., & Chrousos, G. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962300 · Cited by 290 · cited 1×
“Because high doses of interleukin-6 increase plasma levels of vasopressin in humans (32), endogenous interleukin-6 may also participate in the pathogenesis of this syndrome.”
BackgroundSelf-citationTreatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.
Wendling, D., Racadot, E., & Wijdenes, J. (1993) · PubMed · Cited by 276
Peters, M. J., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Büschenfelde, K. H. M. Z., & Rose‐John, S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D. W., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117100 · Cited by 269
Self-citationVankelecom, H. E. J., Carmeliet, P., Damme, J. V., Billiau, A., & Denef, C. (2008) · Neuroendocrinology · doi:10.1159/000125097 · Cited by 266
Dysregulated interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice
Brandt, S. J., Bodine, D. M., Dunbar, C. E., & Nienhuis, A. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114749 · Cited by 248
Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., & Quirion, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91327-o · Cited by 244
Crofford, L. J. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.4.1279 · Cited by 242
Wolbink, G., Brouwer, M. C., Buysmann, S., ten Berge, I. J. M., & Hack, C. E. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.473 · Cited by 233
Papanicolaou, D. A., Petrides, J. S., Tsigos, C., Bina, S., Kalogeras, K. T., Wilder, R. L., Gold, P. W., Deuster, P. A., & Chrousos, G. P. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.3.e601 · Cited by 226
Self-citationde Benedetti, F., Massa, M., Pignatti, P., Albani, S., Novick, D., & Martini, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117206 · Cited by 224
Tsigos, C., Papanicolaou, D. A., Defensor, R., Mitsiadis, C. S., Kyrou, I., & Chrousos, G. P. (2008) · Neuroendocrinology · doi:10.1159/000127219 · Cited by 223
Self-citationInterleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease.
Devlin, R., Bone, H., & Roodman, G. D. (1996) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.81.5.8626854 · Cited by 201
Gold, P. W., Licinio, J., Wong, M., & Chrousos, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44723.x · Cited by 199
Self-citationAssociation between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness.
Boelen, A., Platvoet-Ter Schiphorst, M. C., & Wiersinga, W. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263160 · Cited by 196
Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
Passeri, G., Girasole, G., Jilka, R. L., & Manolagas, S. C. (1993) · Endocrinology · doi:10.1210/endo.133.2.8393776 · Cited by 186
Self-citationThe Effect of Interleukin-6 on Pituitary Hormone Release in vivo and in vitro
Lyson, K., & McCann, S. M. (2008) · Neuroendocrinology · doi:10.1159/000125884 · Cited by 179
Yamamoto, T., Ozono, K., Kasayama, S., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118773 · Cited by 179
The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat
Gool, J. V., van Vugt, H., Helle, M., & Aarden, L. A. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90034-n · Cited by 179
Interleukin-6 and selected plasma proteins in healthy persons of different ages
Häger, K., Machein, U., Krieger, S., Platt, D., Seefried, G., & Bauer, J. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90066-3 · Cited by 172
Salvi, M., Girasole, G., Pedrazzoni, M., Passeri, M., Giuliani, N., Minelli, R., Braverman, L. E., & Roti, E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768861 · Cited by 166
Bellido, T., Stahl, N., Farruggella, T. J., Borba, V. Z. C., Yancopoulos, G. D., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118432 · Cited by 164
Self-citationInterleukin-6 mediates host defense responses induced by abdominal surgery.
Wortel, C. H., van Deventer, S. J. H., Aarden, L. A., Lygidakis, N. J., Buller, H. R., Hoek, F. J., Horikx, J., & ten Cate, J. W. (1993) · PubMed · Cited by 161
C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivo
Bataille, R., & Klein, B. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350824 · Cited by 160
Production of interleukin-6 by normal human trophoblast
Kameda, T., Matsuzaki, N., Sawai, K., Okada, T., Saji, F., Matsuda, T., Hirano, T., Kishimoto, T., & Tanizawa, O. (1990) · Placenta · doi:10.1016/s0143-4004(05)80266-8 · Cited by 151
Grey, A. B., Mitnick, M. A., Shapses, S. A., Ellison, A. F., Gundberg, C. M., & Insogna, K. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855783 · Cited by 146
Interleukin‐1 regulation of hematopoietic growth factor production by human stromal fibroblasts
Yang, Y., Tsai, S., Wong, G., et al. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041340217 · Cited by 133
Papanicolaou, D. A., Tsigos, C., Oldfield, E. H., & Chrousos, G. P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964868 · Cited by 128
Self-citationLin, S., Yamate, T., Taguchi, Y., Borba, V. Z. C., Girasole, G., O’Brien, C. A., Bellido, T., Abe, E., & Manolagas, S. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119729 · Cited by 128
Self-citationVizi, E. S., Orsó, E., Osipenko, O. N., et al. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00215-5 · Cited by 117
Cerebrospinal fluid cytokines in AIDS dementia complex
Perrella, O., Carrieri, P. B., Guarnaccia, D., & Soscia, M. (1992) · Journal of Neurology · doi:10.1007/bf00812156 · Cited by 114
McGee, D. W., Beagley, K. W., Aicher, W. K., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.970 · Cited by 111
Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?
Spronk, P., ter Borg, E. J., Limburg, P. C., et al. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb05840.x · Cited by 108
CNS regulation of thermogenesis.
Rothwell, N. J. (1994) · PubMed · Cited by 103
Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis.
Wilder, R. L. (1996) · PubMed · Cited by 101
Self-citationKopf, M., Ramsay, A., Brombacher, F., Baumann, H., Freer, G., Galanos, C., Gutiérrez-Ramos, J., & Köhler, G. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32335.x · Cited by 101
Cytokine abnormalities in human lupus
Linker‐Israeli, M. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90084-2 · Cited by 93
Regulation of IL6 gene expression
Sehgal, P. B. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80011-9 · Cited by 91
Culley, F. J., Harris, R. A., Kaye, P. M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4691 · Cited by 88
Gabay, C., Roux-Lombard, P., de Moerloose, P., et al. (1993) · PubMed · Cited by 84
Certain Endocrine and Metabolic Facets of the Steroid Withdrawal Syndrome
AMATRUDA, T. T., HURST, A. M., & D’Esopo, N. D. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-9-1207 · Cited by 83
Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H., & Fiers, W. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240945 · Cited by 82
Soszyński, D., Kozak, W., Conn, C. A., Rudolph, K., & Kluger, M. J. (2008) · Neuroendocrinology · doi:10.1159/000127072 · Cited by 80
Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy
Langub, M. C., Koszewski, N. J., Turner, H. V., et al. (1996) · Kidney International · doi:10.1038/ki.1996.343 · Cited by 65
Breuninger, L. M., Dempsey, W. L., Uhl, J., & Murasko, D. M. (1993) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1993.1171 · Cited by 61
Long-Term Consequences of Interleukin-6 Overexpression in Transgenic Mice
Woodroofe, C., Müller, W., & Rüther, U. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.587 · Cited by 61
Tanabe, M., Ochi, T., Tomita, T., et al. (1994) · PubMed · Cited by 56
Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans.
Rock, C. S., Coyle, S. M., Keogh, C. V., et al. (1992) · PubMed · Cited by 52
Constitutive production of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium
Miyasaka, N., Sato, K., Hashimoto, J., Kohsaka, H., Yamamoto, K., Goto, M., Inoue, K., Matsuda, T., Hirano, T., Kishimoto, T., et al. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90175-x · Cited by 51
Swaak, A. J. G., van Rooyen, A., & Aarden, L. (1989) · Rheumatology International · doi:10.1007/bf00270982 · Cited by 50
Interleukin-6 secretion from rat Leydig cells in culture.
Boockfor, F. R., Wang, D., Lin, T., et al. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156916 · Cited by 50
Leeuwen, M. A. V., Westra, J., Limburg, P. C., van Riel, P. L., & van Rijswijk, M. H. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.8.674 · Cited by 48
Changes in Plasma Cholesterol Levels after Hospitalization for Acute Coronary Events
Brugada, R., WENGER, N. K., Jacobson, T. A., et al. (2008) · Cardiology · doi:10.1159/000177086 · Cited by 36
A Nuclear Factor for the IL-6 Gene (NF-IL6)
Akira, S., Isshiki, H., Nakajima, T., et al. (1992) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000319094 · Cited by 30
Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing
Masi, A. T., & Chrousos, G. P. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.1.1 · Cited by 25
Self-citationRothwell, N. J. (1993) · PubMed · Cited by 21
The plasma interleukin-6 and stress hormone responses to acute pyelonephritis
Donald, R. A., Bailey, R. R., Hart, D. N. J., Livesey, J., Evans, M. J., Mattioli, L., Macdonald, J., & Smith, A. H. W. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03348973 · Cited by 14
Cytokines and adrenal insufficiency
Papanicolaou, D. A. (1997) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199706000-00002 · Cited by 6
Self-citation
Cited by
Sorted by citations
Psychological stress and the human immune system: a meta-analytic study of 30 Years of inquiry
Segerstrom, S. C., & Miller, G. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.4.601 · Cited by 3,334
Stress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215
Self-citationElevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Walston, J., Hadley, E. C., Ferrucci, L., Guralnik, J. M., Newman, A. B., Studenski, S. A., Ershler, W. B., Harris, T., & Fried, L. P. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00745.x · Cited by 1,605
Metadata
- Authors
- Papanicolaou, D. A., Wilder, R. L., Manolagas, S. C., & Chrousos, G. P.
- Affiliations
- An edited summary of a Clinical Staff Conference held on 13 March 1996 at the National Institutes of Health, Bethesda, Maryland.
- Corresponding author
- Papanicolaou, Dimitris A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1998-01-15
- Volume
- 128
- Issue
- 2
- Pages
- 127-137
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1985953874
- Cited by
- 1,146
- References
- 103
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 17 · 2023: 20 · 2022: 22 · 2021: 29 · 2020: 23 · 2019: 17 · 2018: 27 · 2017: 25 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 37 · 2012: 60
- FWCI
- 18.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- interleukin-6, inflammatory cytokines, hypothalamic-pituitary-adrenal axis, glucocorticoid negative feedback, growth hormone secretion, serum lipids, fever, vasopressin, rheumatoid arthritis, sex steroids, osteoporosis, bone resorption, aging, chronic stress
- MeSH terms
- Aging, Autoimmune Diseases, Bone Diseases, Endocrine System, Female, Humans, Immune System, Inflammation, Interleukins, Male, Osteoporosis, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
